Gyre Therapeutics Stock (NASDAQ: GYRE) stock price, news, charts, stock research, profile.
Open | $16.330 |
Close | $17.110 |
Volume / Avg. | 190.253K / 77.701K |
Day Range | 15.900 - 17.250 |
52 Wk Range | 5.880 - 30.400 |
Market Cap | $1.427B |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 53 |
Short Interest | - |
Days to Cover | 2.3 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Gyre Therapeutics (NASDAQ: GYRE) through any online brokerage.
Other companies in Gyre Therapeutics’s space includes: Twist Bioscience (NASDAQ:TWST), 4D Molecular Therapeutics (NASDAQ:FDMT), Syndax Pharmaceuticals (NASDAQ:SNDX), Day One Biopharmaceutical (NASDAQ:DAWN) and Xencor (NASDAQ:XNCR).
There is no analysis for Gyre Therapeutics.
The stock price for Gyre Therapeutics (NASDAQ: GYRE) is $16 last updated April 16, 2024 at 4:00 PM EDT.
There are no upcoming dividends for Gyre Therapeutics.
Gyre Therapeutics’s Q1 earnings are confirmed for Friday, May 10, 2024.
There is no upcoming split for Gyre Therapeutics.
Gyre Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.